Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
[Acute drug-induced tubulo-interstitial nephropathies].

Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille

Lepoutre E.
PMID: 1004121
Lille Med. 1976 Oct;21(8):685-9.

No abstract available.

Cite
Lepoutre E. Néphropathies tubulo-interstitielles aiguës médicamenteuses [Acute drug-induced tubulo-interstitial nephropathies]. Lille Med. 1976;21(8):685-9
Lepoutre, E. (1976). Néphropathies tubulo-interstitielles aiguës médicamenteuses [Acute drug-induced tubulo-interstitial nephropathies]. Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 21(8), 685-9.
Lepoutre, E. "Néphropathies tubulo-interstitielles aiguës médicamenteuses" [Acute drug-induced tubulo-interstitial nephropathies]. Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille vol. 21,8 (1976): 685-9.
Lepoutre E. Néphropathies tubulo-interstitielles aiguës médicamenteuses [Acute drug-induced tubulo-interstitial nephropathies]. Lille Med. 1976 Oct;21(8):685-9. French. PMID: 1004121.
Copy Download .nbib Format: NLM
[Nephrotoxicity of drugs].

Soins; la revue de reference infirmiere

Breuillard P.
PMID: 588063
Soins. 1977 Aug 5-20;22(15):41-4.

No abstract available.

Cite
Breuillard P. Néphrotoxicité des médicaments. [Nephrotoxicity of drugs]. Soins. 1977;22(15):41-4
Breuillard, P. (1977). Néphrotoxicité des médicaments. [Nephrotoxicity of drugs]. Soins; la revue de reference infirmiere, 22(15), 41-4.
Breuillard, P. "Néphrotoxicité des médicaments." [Nephrotoxicity of drugs]. Soins; la revue de reference infirmiere vol. 22,15 (1977): 41-4.
Breuillard P. Néphrotoxicité des médicaments. [Nephrotoxicity of drugs]. Soins. 1977 Aug 5-20;22(15):41-4. French. PMID: 588063.
Copy Download .nbib Format: NLM
Toxic nephropathy. An occult disease of medical progress.

Acta clinica Belgica

Maher JF.
PMID: 5974090
Acta Clin Belg. 1966;21(5):283-7. doi: 10.1080/17843286.1966.11716617.

No abstract available.

Cite
Maher JF. Toxic nephropathy. An occult disease of medical progress. Acta Clin Belg. 1966;21(5):283-7doi: 10.1080/17843286.1966.11716617.
Maher, J. F. (1966). Toxic nephropathy. An occult disease of medical progress. Acta clinica Belgica, 21(5), 283-7. https://doi.org/10.1080/17843286.1966.11716617
Maher, J F. "Toxic nephropathy. An occult disease of medical progress." Acta clinica Belgica vol. 21,5 (1966): 283-7. doi: https://doi.org/10.1080/17843286.1966.11716617
Maher JF. Toxic nephropathy. An occult disease of medical progress. Acta Clin Belg. 1966;21(5):283-7. doi: 10.1080/17843286.1966.11716617. PMID: 5974090.
Copy Download .nbib Format: NLM
[Current problems of drug treatment in nephrology].

Terapevticheskii arkhiv

Mukhin NA, Nikolaev AIu, Tareeva IE.
PMID: 2686072
Ter Arkh. 1989;61(8):3-6.

No abstract available.

Cite
Mukhin NA, Nikolaev AIu, Tareeva IE. Aktual'nye voprosy lekarstvennogo lecheniia v nefrologii. [Current problems of drug treatment in nephrology]. Ter Arkh. 1989;61(8):3-6
Mukhin, N. A., Nikolaev, A. I. u., & Tareeva, I. E. (1989). Aktual'nye voprosy lekarstvennogo lecheniia v nefrologii. [Current problems of drug treatment in nephrology]. Terapevticheskii arkhiv, 61(8), 3-6.
Mukhin, N A, et al. "Aktual'nye voprosy lekarstvennogo lecheniia v nefrologii." [Current problems of drug treatment in nephrology]. Terapevticheskii arkhiv vol. 61,8 (1989): 3-6.
Mukhin NA, Nikolaev AIu, Tareeva IE. Aktual'nye voprosy lekarstvennogo lecheniia v nefrologii. [Current problems of drug treatment in nephrology]. Ter Arkh. 1989;61(8):3-6. Russian. PMID: 2686072.
Copy Download .nbib Format: NLM
Radiocontrast media nephrotoxicity. Clinical aspects.

Contributions to nephrology

Arrigo G, Cavaliere G, Scalia A, Schiavina G, D'Amico G.
PMID: 3549149
Contrib Nephrol. 1987;55:176-84.

No abstract available.

Cite
Arrigo G, Cavaliere G, Scalia A, et al. Radiocontrast media nephrotoxicity. Clinical aspects. Contrib Nephrol. 1987;55:176-84
Arrigo, G., Cavaliere, G., Scalia, A., Schiavina, G., & D'Amico, G. (1987). Radiocontrast media nephrotoxicity. Clinical aspects. Contributions to nephrology, 55176-84.
Arrigo, G, et al. "Radiocontrast media nephrotoxicity. Clinical aspects." Contributions to nephrology vol. 55 (1987): 176-84.
Arrigo G, Cavaliere G, Scalia A, Schiavina G, D'Amico G. Radiocontrast media nephrotoxicity. Clinical aspects. Contrib Nephrol. 1987;55:176-84. PMID: 3549149.
Copy Download .nbib Format: NLM
Drug-induced kidney diseases.

The Journal of the Association of Physicians of India

Singh NP, Ganguli A, Prakash A.
PMID: 14719587
J Assoc Physicians India. 2003 Oct;51:970-9.

Drug-induced kidney disease constitutes an important cause of acute renal failure and chronic kidney disease in present day clinical practice. Different classes of drugs, by virtue of immunological mechanisms or direct toxicity initiate certain stereotyped renal responses. For most...

Cite
Singh NP, Ganguli A, Prakash A. Drug-induced kidney diseases. J Assoc Physicians India. 2003;51:970-9
Singh, N. P., Ganguli, A., & Prakash, A. (2003). Drug-induced kidney diseases. The Journal of the Association of Physicians of India, 51970-9.
Singh, N P, et al. "Drug-induced kidney diseases." The Journal of the Association of Physicians of India vol. 51 (2003): 970-9.
Singh NP, Ganguli A, Prakash A. Drug-induced kidney diseases. J Assoc Physicians India. 2003 Oct;51:970-9. PMID: 14719587.
Copy Download .nbib Format: NLM
Kidney lesions in sulfa therapy and radiographic visibility of the calculations of said origin.

Archivos espanoles de urologia

BERGLIN T.
PMID: 20249358
Arch Esp Urol. 1947 Apr;3(4):302-19.

No abstract available.

Cite
BERGLIN T. Las lesiones renales en la terapeutica sulfamidica y la visibilidad radiografica de los calculos de dicho origen. Kidney lesions in sulfa therapy and radiographic visibility of the calculations of said origin. Arch Esp Urol. 1947;3(4):302-19
BERGLIN, T. (1947). Las lesiones renales en la terapeutica sulfamidica y la visibilidad radiografica de los calculos de dicho origen. Kidney lesions in sulfa therapy and radiographic visibility of the calculations of said origin. Archivos espanoles de urologia, 3(4), 302-19.
BERGLIN, T. "Las lesiones renales en la terapeutica sulfamidica y la visibilidad radiografica de los calculos de dicho origen." Kidney lesions in sulfa therapy and radiographic visibility of the calculations of said origin. Archivos espanoles de urologia vol. 3,4 (1947): 302-19.
BERGLIN T. Las lesiones renales en la terapeutica sulfamidica y la visibilidad radiografica de los calculos de dicho origen. Kidney lesions in sulfa therapy and radiographic visibility of the calculations of said origin. Arch Esp Urol. 1947 Apr;3(4):302-19. Spanish. PMID: 20249358.
Copy Download .nbib Format: NLM
SGLT2 inhibitors and the kidney: Effects and mechanisms.

Diabetes & metabolic syndrome

Tsimihodimos V, Filippatos TD, Elisaf MS.
PMID: 29909004
Diabetes Metab Syndr. 2018 Nov;12(6):1117-1123. doi: 10.1016/j.dsx.2018.06.003. Epub 2018 Jun 06.

AIMS: Numerous clinical trials have shown that sodium glucose cotransporter 2 (SGLT2) inhibitors exert a favorable effect on the indices of renal function (albuminuria, glomerular filtration rate decline over time) and the incidence of hard renal endpoints such as...

Cite
Tsimihodimos V, Filippatos TD, Elisaf MS. SGLT2 inhibitors and the kidney: Effects and mechanisms. Diabetes Metab Syndr. 2018;12(6):1117-1123doi: 10.1016/j.dsx.2018.06.003.
Tsimihodimos, V., Filippatos, T. D., & Elisaf, M. S. (2018). SGLT2 inhibitors and the kidney: Effects and mechanisms. Diabetes & metabolic syndrome, 12(6), 1117-1123. https://doi.org/10.1016/j.dsx.2018.06.003
Tsimihodimos, V, et al. "SGLT2 inhibitors and the kidney: Effects and mechanisms." Diabetes & metabolic syndrome vol. 12,6 (2018): 1117-1123. doi: https://doi.org/10.1016/j.dsx.2018.06.003
Tsimihodimos V, Filippatos TD, Elisaf MS. SGLT2 inhibitors and the kidney: Effects and mechanisms. Diabetes Metab Syndr. 2018 Nov;12(6):1117-1123. doi: 10.1016/j.dsx.2018.06.003. Epub 2018 Jun 06. PMID: 29909004.
Copy Download .nbib Format: NLM
Pharmacology behind Common Drug Nephrotoxicities.

Clinical journal of the American Society of Nephrology : CJASN

Perazella MA.
PMID: 29622670
Clin J Am Soc Nephrol. 2018 Dec 07;13(12):1897-1908. doi: 10.2215/CJN.00150118. Epub 2018 Apr 05.

Patients are exposed to numerous prescribed and over-the-counter medications. Unfortunately, drugs remain a relatively common cause of acute and chronic kidney injury. A combination of factors including the innate nephrotoxicity of drugs, underlying patient characteristics that increase their risk...

Cite
Perazella MA. Pharmacology behind Common Drug Nephrotoxicities. Clin J Am Soc Nephrol. 2018;13(12):1897-1908doi: 10.2215/CJN.00150118.
Perazella, M. A. (2018). Pharmacology behind Common Drug Nephrotoxicities. Clinical journal of the American Society of Nephrology : CJASN, 13(12), 1897-1908. https://doi.org/10.2215/CJN.00150118
Perazella, Mark A. "Pharmacology behind Common Drug Nephrotoxicities." Clinical journal of the American Society of Nephrology : CJASN vol. 13,12 (2018): 1897-1908. doi: https://doi.org/10.2215/CJN.00150118
Perazella MA. Pharmacology behind Common Drug Nephrotoxicities. Clin J Am Soc Nephrol. 2018 Dec 07;13(12):1897-1908. doi: 10.2215/CJN.00150118. Epub 2018 Apr 05. PMID: 29622670; PMCID: PMC6302342.
Copy Download .nbib Format: NLM
[Renal aspects of sodium glucose cotransporter 2 inhibitors].

Revue medicale suisse

Beaud F, Pruijm M, Humbert A, Burnier M, Zanchi A.
PMID: 25898456
Rev Med Suisse. 2015 Feb 25;11(463):488-92.

It has been known for centuries that the kidneys play a role in glucose homeostasis, yet the underlying tubular mechanisms have only been recently identified by studying patients with familial glucosuria. These insights have lead to the commercialization of...

Cite
Beaud F, Pruijm M, Humbert A, et al. Les inhibiteurs du cotransporteur SGLT2 comme nouveau traitement du diabète: aspects rénaux. [Renal aspects of sodium glucose cotransporter 2 inhibitors]. Rev Med Suisse. 2015;11(463):488-92
Beaud, F., Pruijm, M., Humbert, A., Burnier, M., & Zanchi, A. (2015). Les inhibiteurs du cotransporteur SGLT2 comme nouveau traitement du diabète: aspects rénaux. [Renal aspects of sodium glucose cotransporter 2 inhibitors]. Revue medicale suisse, 11(463), 488-92.
Beaud, F, et al. "Les inhibiteurs du cotransporteur SGLT2 comme nouveau traitement du diabète: aspects rénaux." [Renal aspects of sodium glucose cotransporter 2 inhibitors]. Revue medicale suisse vol. 11,463 (2015): 488-92.
Beaud F, Pruijm M, Humbert A, Burnier M, Zanchi A. Les inhibiteurs du cotransporteur SGLT2 comme nouveau traitement du diabète: aspects rénaux. [Renal aspects of sodium glucose cotransporter 2 inhibitors]. Rev Med Suisse. 2015 Feb 25;11(463):488-92. French. PMID: 25898456.
Copy Download .nbib Format: NLM
Histological study of the action of 1162 F on the rat kidney.

Journal d'urologie medicale et chirurgicale

GOUYGOU C.
PMID: 20258775
J Urol Medicale Chir. 1947 Apr-Jun;53(4):118-21.

No abstract available.

Cite
GOUYGOU C. Etude histologique de l'action du 1162 F sur le rein du rat. Histological study of the action of 1162 F on the rat kidney. J Urol Medicale Chir. 1947;53(4):118-21
GOUYGOU, C. (1947). Etude histologique de l'action du 1162 F sur le rein du rat. Histological study of the action of 1162 F on the rat kidney. Journal d'urologie medicale et chirurgicale, 53(4), 118-21.
GOUYGOU, C. "Etude histologique de l'action du 1162 F sur le rein du rat." Histological study of the action of 1162 F on the rat kidney. Journal d'urologie medicale et chirurgicale vol. 53,4 (1947): 118-21.
GOUYGOU C. Etude histologique de l'action du 1162 F sur le rein du rat. Histological study of the action of 1162 F on the rat kidney. J Urol Medicale Chir. 1947 Apr-Jun;53(4):118-21. French. PMID: 20258775.
Copy Download .nbib Format: NLM
Nanomedicines for kidney diseases.

Kidney international

Williams RM, Jaimes EA, Heller DA.
PMID: 27292222
Kidney Int. 2016 Oct;90(4):740-5. doi: 10.1016/j.kint.2016.03.041. Epub 2016 Jun 09.

Nanomedicines have been the subject of great interest for the treatment, diagnosis, and research of disease; however, few specifically address kidney disorders. Nanotechnology can confer significant benefits to medicine, such as the targeted delivery of drugs to specific tissues....

Cite
Williams RM, Jaimes EA, Heller DA. Nanomedicines for kidney diseases. Kidney Int. 2016;90(4):740-5doi: 10.1016/j.kint.2016.03.041.
Williams, R. M., Jaimes, E. A., & Heller, D. A. (2016). Nanomedicines for kidney diseases. Kidney international, 90(4), 740-5. https://doi.org/10.1016/j.kint.2016.03.041
Williams, Ryan M, et al. "Nanomedicines for kidney diseases." Kidney international vol. 90,4 (2016): 740-5. doi: https://doi.org/10.1016/j.kint.2016.03.041
Williams RM, Jaimes EA, Heller DA. Nanomedicines for kidney diseases. Kidney Int. 2016 Oct;90(4):740-5. doi: 10.1016/j.kint.2016.03.041. Epub 2016 Jun 09. PMID: 27292222; PMCID: PMC5064150.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries